Rush University is a private research university in Chicago, Illinois. The university, founded in 1972, is the academic arm of Rush University Medical Center.

During the past decade, Rush University conducted 51 clinical trials. In the 10-year time frame, 51 clinical trials started and 26 clinical trials were completed, i.e. on average, 51% percent of trials that started reached the finish line to date. In the past 5 years, 24 clinical trials started and 20 clinical trials were completed. i.e. 83.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Rush University" #1 sponsor was "Rush University Medical Center" with 3 trials, followed by "Aerin Medical" with 2 trials sponsored, "C. R. Bard" with 2 trials sponsored, "Emory University" with 2 trials sponsored and "Janssen Research & Development, LLC" with 2 trials sponsored. Other sponsors include 61 different institutions and companies that sponsored additional 65 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Rush University" #1 collaborator was "National Institute of Neurological Disorders and Stroke (NINDS)" with 6 trials as a collaborator, "National Institute on Aging (NIA)" with 4 trials as a collaborator, "Rush University" with 4 trials as a collaborator, "Emissary International LLC" with 3 trials as a collaborator and "Genentech, Inc." with 3 trials as a collaborator. Other collaborators include 84 different institutions and companies that were collaborators in the rest 83 trials.

According to Clinical.Site data, the most researched conditions in "Rush University" are "Autism Spectrum Disorder" (3 trials), "Intracerebral Hemorrhage" (3 trials), "Stroke" (3 trials), "Alzheimer Disease" (2 trials) and "Delayed Graft Function" (2 trials). Many other conditions were trialed in "Rush University" in a lesser frequency.

Most popular intervention types in "Rush University" are "Drug" (37 trials), "Device" (16 trials), "Other" (16 trials), "Procedure" (7 trials) and "Behavioral" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "MT-3724" (2 trials), "Paclitaxel" (2 trials), "Pembrolizumab" (2 trials) and "Standard Care" (2 trials). Other intervention names were less common.

The vast majority of trials in "Rush University" are 73 trials for "All" genders, 3 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Rush University". undefined are not yet recruiting, 15 are recruiting, 9 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 37 completed trials in Rush University, 1 suspended trials, and 13 terminated clinical trials to date.

Out of the total trials that were conducted in Rush University, 4 "Phase 1" clinical trials were conducted, 19 "Phase 2" clinical trials and 21 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 20 trials that are defined as “Not Applicable".